During the past decade, Synexus North East Clinical Research Centre - Hexham General Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus North East Clinical Research Centre - Hexham General Hospital" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Celgene" with 2 trials sponsored, "Phathom Pharmaceuticals, Inc." with 2 trials sponsored and "Kowa Research Institute, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus North East Clinical Research Centre - Hexham General Hospital" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Synexus North East Clinical Research Centre - Hexham General Hospital" are "Cardiovascular Disease" (2 trials), "Eosinophilic Esophagitis" (2 trials), "Hyperlipidemia" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Synexus North East Clinical Research Centre - Hexham General Hospital" in a lesser frequency.

Most popular intervention types in "Synexus North East Clinical Research Centre - Hexham General Hospital" are "Drug" (15 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Bococizumab (PF-04950615; RN316)" (2 trials), "CC-93538" (2 trials), "Lansoprazole" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus North East Clinical Research Centre - Hexham General Hospital" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Synexus North East Clinical Research Centre - Hexham General Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Synexus North East Clinical Research Centre - Hexham General Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus North East Clinical Research Centre - Hexham General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".